The investment company BWK acquires minority interest in Xactools

Mannheim/ Stutt­gart — The inter­na­tio­nally active manage­ment consul­tancy Homburg & Part­ner advi­sed BWK GmbH Unter­neh­mens­be­tei­li­gungs­ge­sell­schaft on the acqui­si­tion of a mino­rity stake in Xactools GmbH and conduc­ted the commer­cial due diligence.

In addi­tion to BWK, the main share­hol­der is the mana­ging part­ner Thomas Erb. Xactools was foun­ded in 2012 and is a company specia­li­zing in the produc­tion of complex auto­ma­tion solu­ti­ons in the field of measu­re­ment and test­ing tech­no­logy. Thanks to its high level of tech­ni­cal know-how and inno­va­tive ability, the company has been able to estab­lish an estab­lished custo­mer base with well-known auto­mo­tive suppli­ers and well-known mecha­ni­cal engi­nee­ring compa­nies over the past few years.

Xactools distin­gu­is­hes itself through custo­mi­zed produc­tion of special machi­nes for measu­ring and test­ing tech­no­logy. The incre­asing comple­xity of many end products requi­res incre­asing quality assu­rance and quality proofs in combi­na­tion with higher effi­ci­ency in manu­fac­tu­ring. Measu­re­ment systems enable compa­nies to detect defects in the product and in produc­tion and to docu­ment them. These high demands are met by Xactools GmbH, which deve­lops ever more complex and accu­rate measu­ring and test­ing systems.

About Homburg & Partner
Homburg & Part­ner (H&P) is a specia­li­zed manage­ment consul­tancy with a focus on market stra­tegy, sales and pricing. The Private Equity Compe­tence Center combi­nes metho­do­lo­gi­cal and indus­try exper­tise to support compa­nies along the entire invest­ment process. In doing so, H&P focu­ses on the follo­wing seven indus­tries in parti­cu­lar with commer­cial due dili­gence and value enhance­ment projects:
1. auto­mo­tive (espe­ci­ally tier 1 and tier 2 suppliers)
2. cons­truc­tion and buil­ding mate­ri­als (ever­y­thing around the building)
3. chemis­try (espe­ci­ally specialty chemistry)
4. health­care (espe­ci­ally medi­cal tech­no­logy, phar­maceu­ti­cals and OTC)
5. indus­trial goods and mecha­ni­cal engi­nee­ring (in parti­cu­lar compo­nent suppli­ers and service providers)
6. consu­mer invest­ment goods
7. infor­ma­tion & commu­ni­ca­tion tech­no­logy (espe­ci­ally software)

The commer­cial due dili­gence was perfor­med by the Private Equity Compe­tence Center:
Alex­an­der Lüring (Part­ner CC Private Equity)
Felix Pleu­ger (Consul­tant CC Private Equity)